NCT04415593View on ClinicalTrials.gov

High and Low Dose Oral Peanut Immunotherapy - Comparison of Efficacy and Safety

NARecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

September 1, 2020

Primary Completion Date

May 30, 2024

Study Completion Date

May 30, 2024

Conditions
Peanut Allergy
Interventions
DIETARY_SUPPLEMENT

High dose of peanuts

Patients will receive a high dose of ground peanuts (300 mg) mixed with apple mousse (supposing child tolerates apple). For the transparency of the study all patients will receive the same commercially prepared apple product

DIETARY_SUPPLEMENT

Low dose of peanuts

Patients will receive a low dose of ground peanuts (150 mg) mixed with apple mousse (supposing child tolerates apple). For the transparency of the study all patients will receive the same commercially prepared apple product

Trial Locations (1)

02-091

RECRUITING

Department of Pediatric Pneumonology and Allergy, Medical University of Warsaw, Warsaw

All Listed Sponsors
lead

Medical University of Warsaw

OTHER